Neuropilin 1: function and therapeutic potential in cancer Belal ChaudharyYazan S. KhaledEyad Elkord Review 22 November 2013 Pages: 81 - 99
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers Mary L. DisisYushe DangLupe G. Salazar Original Article 26 October 2013 Pages: 101 - 109
Critical role of spatial interaction between CD8+ and Foxp3+ cells in human gastric cancer: the distance matters Anita FeichtenbeinerMatthias HaasLuitpold V. Distel Original Article 30 October 2013 Pages: 111 - 119
An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression Pengfei ZhangBizhi ShiZonghai Li Original Article 01 November 2013 Pages: 121 - 132
Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial Ryan D. GuestNatalia KirillovaDavid E. Gilham Original Article 05 November 2013 Pages: 133 - 145
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study Peggy J. de Vos van SteenwijkMariette I. E. van PoelgeestGemma G. Kenter Original Article 15 November 2013 Pages: 147 - 160
Identification and characterization of agonist epitopes of the MUC1-C oncoprotein Caroline JochemsJo A. TuckerKwong-Yok Tsang Original Article 15 November 2013 Pages: 161 - 174
The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer Nicola E. AnnelsVictoria E. ShawGary Middleton Original Article 29 November 2013 Pages: 175 - 183
Advances in cellular therapy: 7th international symposium on the clinical use of cellular products, March 14 and 15, 2013, Erlangen, Germany Michael AignerHeiko BrunsArmin Gerbitz Meeting Report 05 November 2013 Pages: 185 - 193
